ImmunityBio, Inc. , a commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to ...
Regulatory authorities emphasize integrated control strategies, but CAR-T specification setting requires balancing data rigor with regulatory flexibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback